Oto Takahiro
Department of Cancer and Thoracic Surgery, Okayama University Hospital, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
Gen Thorac Cardiovasc Surg. 2008 Nov;56(11):533-8. doi: 10.1007/s11748-008-0315-y. Epub 2008 Nov 12.
Although lung transplantation is a well-accepted treatment for advanced lung diseases, donor shortage remains a significant limiting factor resulting in an increasing number of deaths of people on waiting lists. Recently, some transplant centers have begun to use lungs retrieved from donors after circulatory arrest. This review outlines the relevant published experimental data and clinical experiences with lung transplantation from donation after cardiac-death donors (DCDs) or non-heart-beating donors (NHBDs). Techniques for lung preservation and ex vivo lung assessment of DCD (NHBD) lungs are reviewed, and aspects of primary graft dysfunction after DCD (NHBD) lung transplantation are discussed.
尽管肺移植是治疗晚期肺部疾病的一种广泛接受的方法,但供体短缺仍然是一个重大限制因素,导致越来越多等待名单上的人死亡。最近,一些移植中心已开始使用循环骤停后从供体获取的肺。本综述概述了已发表的有关心脏死亡供体(DCD)或非心跳供体(NHBD)肺移植的实验数据和临床经验。回顾了DCD(NHBD)肺的肺保存和体外肺评估技术,并讨论了DCD(NHBD)肺移植后原发性移植功能障碍的相关方面。